603127 昭衍新药
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0-100.00%19,52922,59825,2890
投资性房地产0--0000
固定资产669,97614.86%583,319590,214493,153445,556
在建工程323,646-5.37%342,008277,735127,36148,633
无形资产294,0640.58%292,380299,536137,193123,631
商誉134,561-1.06%136,007133,739122,431125,296
其他非流动资产2,768,82580.74%1,531,9503,111,9881,817,166181,795
4,191,07344.26%2,905,1924,435,8102,722,593924,911

流动资产
货币资金1,840,125-35.73%2,862,9122,916,8484,154,099308,690
应收账款213,0423.41%206,014199,437107,60688,866
存货1,631,793-12.41%1,863,0822,194,606700,587406,215
其他流动资产1,649,152-24.69%2,189,959617,516852,192379,140
5,334,112-25.10%7,121,9675,928,4065,814,4841,182,911

流动负债
短期借款0--0000
应付票据0--0000
应付帐款39,305-9.27%43,323127,30953,64460,286
其他流动负债1,259,402-11.56%1,424,0421,716,9531,160,598699,757
1,298,707-11.49%1,467,3651,844,2621,214,242760,042
流动资产净值4,035,405-28.64%5,654,6024,084,1444,600,242422,869
资产总额减流动负债8,226,478-3.89%8,559,7958,519,9537,322,8351,347,779

非流动负债
长期借款0--03,2814,93921,375
应付债券0--0000
其他非流动负债235,643-15.47%278,754325,807173,460102,240
235,643-15.47%278,754329,087178,399123,615

总权益
    实收股本749,477-0.05%749,889535,679381,246227,455
    储备项目7,252,958-3.67%7,529,4277,648,0236,754,968997,444
股东权益8,002,436-3.34%8,279,3168,183,7017,136,2141,224,899
非控股权益(11,601)-772.52%1,7257,1658,222(735)